{"database": "lobbying", "table": "lobbying_activities", "rows": [[3236590, "532d7c3f-36b8-4e88-86f2-bbfe95f3eb9e", "Q3", "CHAMBER HILL STRATEGIES", 400645947, "MAYO COLLABORATIVE SERVICES, INC.", 2024, "third_quarter", "MED", "Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, the VALID Act of 2023; S. 1000/H.R. 2377, the Saving Access to Laboratory Services Act", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2024-10-14T12:03:39-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3236590"], "units": {}, "query_ms": 68.20827699266374, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}